Walleye Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3.63M | Buy |
|
|||||
|
2024
Q2 | $1.57M | Sell |
|
|||||
|
2024
Q1 | $3.06M | Sell |
|
|||||
|
2023
Q4 | $8.16M | Buy |
|
|||||
|
2023
Q3 | $3.51M | Buy |
|
|||||
|
2023
Q2 | $2.88M | Sell |
|
|||||
|
2023
Q1 | $9.03M | Sell |
|
|||||
|
2022
Q4 | $9.39M | Sell |
|
|||||
|
2022
Q3 | $14.1M | Buy |
|
|||||
|
2022
Q2 | $6.43M | Sell |
|
|||||
|
2022
Q1 | $9.86M | Buy |
|
|||||
|
2021
Q4 | $5.83M | Buy |
|
|||||
|
2021
Q3 | $1.52K | Sell |
|
|||||
|
2021
Q2 | $3.17K | Buy |
|
|||||
|
2021
Q1 | $1.96K | Sell |
|
|||||
|
2020
Q4 | $2.02K | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2018
Q3 | $438K | Buy |
|